[go: up one dir, main page]

WO2005097176A3 - Modulation du transport d'oxalate - Google Patents

Modulation du transport d'oxalate Download PDF

Info

Publication number
WO2005097176A3
WO2005097176A3 PCT/US2005/010227 US2005010227W WO2005097176A3 WO 2005097176 A3 WO2005097176 A3 WO 2005097176A3 US 2005010227 W US2005010227 W US 2005010227W WO 2005097176 A3 WO2005097176 A3 WO 2005097176A3
Authority
WO
WIPO (PCT)
Prior art keywords
oxalate
modulating
animal subject
oxalobacter
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/010227
Other languages
English (en)
Other versions
WO2005097176A2 (fr
Inventor
Marguerite Hatch
Ammon B Peck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
University of Florida Research Foundation Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc filed Critical University of Florida
Publication of WO2005097176A2 publication Critical patent/WO2005097176A2/fr
Publication of WO2005097176A3 publication Critical patent/WO2005097176A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des compositions et des méthodes d'amélioration de la vitesse de transport de l'oxalate d'un site parentéral à la lumière intestinale chez un animal. Les compositions et les méthodes sont utiles pour traiter un animal atteint d'une insuffisance rénale. Lorsqu'on augmente le nombre de bactéries Oxalobacter ou d'enzymes Oxalobacter chez l'animal, l'oxalate est transporté à la lumière intestinale et dégradé dans ladite lumière intestinale, ce qui réduit ainsi la charge d'excrétion de l'oxalate effectuée par les reins.
PCT/US2005/010227 2004-03-26 2005-03-25 Modulation du transport d'oxalate Ceased WO2005097176A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55667004P 2004-03-26 2004-03-26
US60/556,670 2004-03-26

Publications (2)

Publication Number Publication Date
WO2005097176A2 WO2005097176A2 (fr) 2005-10-20
WO2005097176A3 true WO2005097176A3 (fr) 2006-02-23

Family

ID=35125619

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/010227 Ceased WO2005097176A2 (fr) 2004-03-26 2005-03-25 Modulation du transport d'oxalate

Country Status (1)

Country Link
WO (1) WO2005097176A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20200118A1 (ar) 2013-07-05 2017-06-16 Oxthera Intellectual Property Ab مدرات الافراز مشتقة من اوكسالوباكتير فورميجينيس
ES2913398T3 (es) 2016-06-13 2022-06-02 Oxthera Intellectual Property Ab Composiciones y métodos para el tratamiento o la prevención de trastornos relacionados con oxalato
WO2020018799A1 (fr) 2018-07-18 2020-01-23 The University Of Chicago Compositions comprenant des peptides dérivés de sel1 et méthodes de traitement/prévention de taux d'oxalate en excès et pathologies/maladies associés à ceux-ci
EP3860628A4 (fr) * 2018-10-04 2022-08-17 OxThera Intellectual Property AB Nouvelle utilisation médicale de bactéries de réduction de l'oxalate
CN114645005B (zh) * 2022-05-18 2022-08-26 中国科学院地理科学与资源研究所 一种假单胞菌及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020102238A1 (en) * 1997-05-23 2002-08-01 Allison Milton J. Materials and methods for treating or preventing oxalate-related disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020102238A1 (en) * 1997-05-23 2002-08-01 Allison Milton J. Materials and methods for treating or preventing oxalate-related disease

Also Published As

Publication number Publication date
WO2005097176A2 (fr) 2005-10-20

Similar Documents

Publication Publication Date Title
WO2009064460A3 (fr) Systèmes de délivrance aux voies gastro-intestinales
WO2006102680A3 (fr) Procede de traitement de brulures des deuxieme et de troisieme degres mettant en oeuvre une solution aqueuse a potentiel d'oxydoreduction
WO2007087468A3 (fr) L'adiponectine pour le traitement de divers troubles
WO2005117870A3 (fr) Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique
WO2007085021A3 (fr) Procedes destines a traiter ou a prevenir une peritonite avec une solution aqueuse a potentiel d'oxydo-reduction
WO2007067874A3 (fr) Systeme a surface unique pour patient
DK1423023T3 (da) Sammensætning med bakteriostatisk og baktericid aktivitet mod bakterielle sporer og vegetative celler samt fremgangsmåde til behandling af födevarer dermed
WO2004080467A3 (fr) Procede de traitement et de prevention de l'hyperparathyroidie par des composes vitaminiques
WO2009080800A3 (fr) Méthode pour réduire le tour de taille par l'administration de bactéries du genre bifidobacterium
WO2009023710A3 (fr) Extrait de houblon enrichi en xanthohumol
WO2009143150A3 (fr) Modulateurs de la phosphatase alcaline intestinale et leurs utilisations
WO2004047673A3 (fr) Traitement des maladies du foie avec des composes actifs de la vitamine d
WO2007146335A3 (fr) Composés et compositions pour le traitement du cancer
WO2008086971A3 (fr) COMPOSITIONS CONTENANT DU β-LACTAME À STABILITÉ ACCRUE DANS UNE SOLUTION AQUEUSE
WO2005097176A3 (fr) Modulation du transport d'oxalate
WO2011067721A3 (fr) Traitement de l'eau
WO2004099235A3 (fr) Bacteriocines et nouvelles souches bacteriennes
WO2006130328A3 (fr) Facteurs de resistance au serum de bacteries a gram positif
WO2006012204A3 (fr) Procede de traitement de troubles inflammatoires au moyen de composes de triptolide
WO2007130575A3 (fr) Protection contre les dégâts oxydatifs dans des cellules
WO2006034035A3 (fr) Traitement de l'ischemie
WO2008005059A3 (fr) Traitement d'infections buccales et du tractus urinaire
WO2006084261A3 (fr) Technique permettant d'accroitre la biodegradation de polyesters aliphatiques-aromatiques suflones par adjonction d'un consortium microbien
WO2008059041A3 (fr) Complémentation d'un déficit de facteur xi par mutants de facteur v
TW200718437A (en) Methods of treating cardiorenal syndrome and hepatorenal syndrome

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase